Jacqueline H Starrett

3PUBLICATIONS
34CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 03, 2025
Dabogratinib (TYRA-300), an FGFR3 Isoform-Selective Inhibitor: Preclinical and Initial Clinical Evidence of Antitumor Activity.

Jacqueline H Starrett, Eric L Allen, Melissa Neal

|Oct 14, 2025
Dabogratinib (TYRA-300), an FGFR3 Isoform-Selective Inhibitor: Preclinical and Initial Clinical Evidence of Antitumor Activity.

Jacqueline H Starrett, Eric L Allen, Melissa Neal

|Mar 13, 2023
Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations.

Michael J Grant, Jacqueline V Aredo, Jacqueline H Starrett

Pageof 1